Review: beta2-agonists are ineffective but increase adverse effects in acute bronchitis without underlying pulmonary disease.
نویسنده
چکیده
منابع مشابه
Do adverse respiratory effects of beta2-agonists contribute to asthma morbidity and mortality?
Short-acting beta2-agonists (SABAs) have been used as first line therapy for the acute relief of bronchoconstriction in asthma for several decades. However, antiinflammatory therapies are now considered the cornerstone of chronic asthma management. Therefore, it is now recommended that unless individual patients are shown to benefit from regular treatment SABAs are used only when required for a...
متن کاملUsers of antiasthma drugs in Iceland: a drug utilization study.
There has been an increasing consensus worldwide on how to treat asthma, and, simultaneously, an increase in the sales of antiasthma drugs. However, little is known about actual drug use, dosage, combinations of drugs, etc., or about the clinical characteristics of patients using these drugs. All individuals with prescriptions for antiasthma drugs, who came to Icelandic pharmacies during March ...
متن کاملManagement of stable chronic obstructive pulmonary disease: a systematic review for a clinical practice guideline.
BACKGROUND Chronic obstructive pulmonary disease (COPD) is a common and disabling condition in adults. Information about therapeutic effectiveness and adverse effects of common treatment options and how clinical and spirometric characteristics affect outcomes is not well known but is important for clinicians caring for patients with stable COPD. PURPOSE To evaluate the effectiveness of COPD m...
متن کاملEffect of theophylline associated with short-acting or long-acting inhaled beta2-agonists in patients with stable chronic obstructive pulmonary disease: a systematic review.
OBJECTIVES To determine whether, in stable patients with chronic obstructive pulmonary disease, administration of theophylline in combination with short-acting or long-acting inhaled beta2-agonists is more efficacious than is a placebo or each of these drugs used in isolation. METHODS A systematic review and meta-analysis were carried out. All randomized and double-blind clinical trials found...
متن کاملβ2-agonists promote host defense against bacterial infection in primary human bronchial epithelial cells
BACKGROUND Airway epithelial cells are critical in host defense against bacteria including Mycoplasma pneumoniae (Mp) in chronic obstructive pulmonary disease (COPD) and asthma. beta2-agonists are mainstay of COPD and asthma therapy, but whether beta2-agonists directly affect airway epithelial host defense functions is unclear. METHODS Epithelial cells from bronchial brushings of normal (n = ...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
عنوان ژورنال:
- ACP journal club
دوره 137 2 شماره
صفحات -
تاریخ انتشار 2002